HIV/AIDS conspiracy beliefs and intention to adopt preexposure prophylaxis among black men who have sex with men in Los Angeles

Abstract

In the United States, black men who have sex with men (MSM) are the group most affected by the HIV/AIDS epidemic. Pre-exposure prophylaxis (PrEP) is an important new HIV prevention strategy that may help reduce new HIV infections among black MSM. This analysis examined the association between HIV/AIDS conspiracy beliefs and intentions to adopt PrEP among 224 black MSM. The likelihood of adopting PrEP was assessed and more than half (60%) of the study population indicated a high intention to adopt PrEP. HIV/AIDS genocidal and treatment-related conspiracies were assessed using scales previously validated with black MSM. Almost two-thirds (63%) endorsed at least one of eight HIV/AIDS conspiracy beliefs presented. In multivariable analyses, black MSM who agreed with the genocidal or treatment-related conspiracy beliefs scales had a lower intention to adopt PrEP (Adjusted Odds Ratio [AOR] = 0.73, 95% CI = 0.54, 0.99 and AOR = 0.36, 95% CI = 0.23, 0.55, respectively). Our findings indicate that preexisting HIV/AIDS conspiracy beliefs may deter some black MSM from adopting PrEP. We suggest strategies PrEP implementers may want to employ to address the influence that HIV/AIDS conspiracy beliefs may have on the adoption of PrEP among black MSM, a population disproportionately affected by HIV/AIDS.

Keywords

African American gay HIV/AIDS conspiracy beliefs pre-exposure prophylaxis medical mistrust

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention. HIV Surveillance Report, 2015; vol. 27, https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2015-vol-27.pdf (November 2016, accessed January 2017).

Baeten

Donnell

Ndase

et al.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

N Engl J Med 2012; 367: 399–410.

Grant

Lama

Anderson

et al.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

N Engl J Med 2010; 363: 2587–2599.

Thigpen

Kebaabetswe

Paxton

et al.

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

N Engl J Med 2012; 367: 423–434.

Highleyman

PrEP use exceeds 79,000 in US pharmacy survey, but some groups lagging behind. National AIDS Manuel website, http://www.aidsmap.com/PrEP-use-exceeds-79000-in-US-pharmacy-survey-but-some-groups-lagging-behind/page/3072084/ (19 July 2016, accessed 5 August 2016).

Snowden

Chen

McFarland

et al. Prevalence and characteristics of users of pre-exposure prophylaxis (PrEP) among men who have sex with men, San Francisco, 2014 in a cross-sectional survey: implications for disparities. Sex Transm Infect. Epub ahead of print 28 June 2016. DOI: 10.1136/sextrans-2015-052382.

Bogart

and Thorburn

Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans?

J Acquir Immune Defic Syndr 2005; 38: 213–218.

Bird

and Bogart

LM.

Conspiracy beliefs about HIV/AIDS and birth control among African Americans: implications for the prevention of HIV, other STIs, and unintended pregnancy.

J Soc Issues 2005; 61: 109–1, 26.

Hutchinson

Begley

Sullivan

et al.

Conspiracy beliefs and trust in information about HIV/AIDS among minority men who have sex with men.

J Acquir Immune Defic Syndr 2007; 45: 603–605.

10.

Westergaard

Beach

Saha

et al.

Racial/ethnic differences in trust in health care: HIV conspiracy beliefs and vaccine research participation.

J Gen Intern Med 2014; 29: 140–146.

11.

Zekeri

Habtemariam

Tameru

et al.

Conspiracy beliefs about HIV/AIDS among HIV-positive African-American patients in rural Alabama.

Psychol Rep 2009; 104: 388–394.

12.

Bogart

and Bird

ST.

Exploring the relationship of conspiracy beliefs about HIV/AIDS to sexual behaviors and attitudes among African-American adults. J Natl Med Assoc 2003; 95: 1057–1065.

13.

Bogart

Wagner

Galvan

et al.

Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. J Acquir Immune Defic Syndr 2010; 53: 648–655.

14.

Bogart

Galvan

Wagner

et al.

Longitudinal association of HIV conspiracy beliefs with sexual risk among black males living with HIV.

AIDS Behav 2011; 15: 1180–1186.

15.

Roberts

Newman

Duan

et al.

HIV vaccine knowledge and beliefs among communities at elevated risk: conspiracies, questions and confusion. J Natl Med Assoc 2005; 97: 1662–1671.

16.

Brooks

Landovitz

Regan

et al.

Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles.

Int J STD AIDS 2015; 26: 1040–1048.

17.

Bauermeister

Meanley

Pingel

et al.

PrEP awareness and perceived barriers among single young men who have sex with men.

Curr HIV Res 2013; 11: 520–527.

18.

Brooks

Kaplan

Lieber

et al.

Motivators, concerns, and barriers to adoption of pre-exposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships.

AIDS Care 2011; 23: 1136–1145.

19.

Golub

Gamarel

Rendina

et al.

From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.

AIDS Patient Care STDs 2013; 27: 248–254.

20.

Kubicek

Cuadra

and Kipke

MD.

Attitudes and perceptions of biomedical HIV prevention methods: voices from young men who have sex with men.

Arch Sex Behav 2015; 44: 487–497.

21.

Pérez Figueroa

Kapadia

Barton

et al.

Acceptability of PrEP uptake among racially/ethnically diverse young men who have sex with men: the P18 study. AIDS Educ Prev 2015; 27: 112–125.

22.

Nattrass

Understanding the origins and prevalence of AIDS conspiracy beliefs in the United States and South Africa.

Sociol Health Illn 2013; 35: 113–129.

23.

Gamarel

and Golub

SA.

Intimacy motivations and pre-exposure prophylaxis (PrEP) adoption intentions among HIV-negative men who have sex with men (MSM) in romantic relationships.

Ann Behav Med 2015; 49: 177–186.

24.

Gersh

Fiorillo

Burghardt

et al.

Attitudes and barriers towards pre-exposure prophylaxis (Prep) among high- risk HIV-seronegative men who have sex with men. J AIDS Clin Res 2014; 5: 335.

25.

Krakower

Mimiaga

Rosenberger

et al.

Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site.

PLoS ONE 2012; 7: e33119.

26.

Ball

Lawson

and Alim

Medical mistrust, conspiracy beliefs & HIV-related behavior among African Americans. J Psychol Behav Sci 2013; 1: 1–7.

27.

Gonzalez

Penedo

Llabre

et al.

Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence.

Ann Behav Med 2007; 34: 46–55.

28.

Scharff

Mathews

Jackson

et al.

More than Tuskegee: understanding mistrust about research participation. J Health Care Poor Underserved 2010; 21: 879–897.

29.

Kelley

Hannans

Kreps

et al.

The community liaison program: a health education pilot program to increase minority awareness of HIV and acceptance of HIV vaccine trials.

Health Educ Res 2012; 27: 746–754.

30.

Eaton

Driffin

Kegler

et al.

The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men.

Am J Public Health 2015; 105: e75–e82.

31.

Fallon

Park

Ogbue

et al.

Awareness and acceptability of pre-exposure HIV prophylaxis among men who have sex with men in Baltimore.

AIDS Behav 2017; 21: 1268–1277.

32.

Strauss

Greene

Phillips

et al.

Exploring patterns of awareness and use of HIV pre-exposure prophylaxis among young men who have sex with men.

AIDS Behav 2017; 21: 1288–1298.

33.

Brooks

Newman

Duan

et al.

HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.

AIDS Care 2007; 19: 52–58.

34.

Russell

Katz

Wang

et al.

Belief in AIDS origin conspiracy theory and willingness to participate in biomedical research studies: findings in whites, blacks, and Hispanics in seven cities across two surveys.

HIV Clin Trials 2011; 12: 37–47.